A new study found that combining cognitive behavioral therapy (CBT) and a wakefulness medication significantly improved levels of fatigue in patients with multiple sclerosis (MS). The findings may ...
Autoimmune specialist Zenas BioPharma has posted a win for its lead candidate, obexelimab, from a mid-stage study in relapsing multiple sclerosis (RMS). During the Phase II MoonStone study ...
JT Lew, PharmD, MBA, highlights that the primary challenges for patients with multiple sclerosis (MS) in accessing prescribed medications include dealing with the shock of the diagnosis, navigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results